Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 12;14:1108682. doi: 10.3389/fimmu.2023.1108682

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Ayoub, Dauvilliers, Barateau, Vermeulen, Mouton-Barbosa, Marcellin, Gonzalez-de-Peredo, Gross, Saoudi and Liblau

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Differentially regulated proteins in the CSF of persons with NT1 compared to controls without neurological disease. (A) In cohort 1, the CSF proteome from 10 NT1 patients was compared to that of 10 controls with somatoform diseases. (B) Principal Component Analysis (PCA) visualization of the first two principal components. (C) Heatmap of proteins with significantly different abundance in the CSF of NT1 patients vs. controls (p-value<0.05; Limma test). (D) Volcano plot representing the fold change (log2) of each protein in NT1 patients compared to controls and the p-value (-Log10), assessed with the Limma test. A significance threshold was set at p ≤ 0.05 (dashed line). (E) The top 10 up-regulated (left) and down-regulated (right) proteins in NT1 patients.